Background: A predictive model may help to select likely responders and to anticipate treatment duration in vitiligo. Methods: We aimed to develop a predictive rule based on data from a randomized trial of excimer laser in vitiligo. Information on 325 treated patches was available. The degree of repigmentation was assessed by digital image analysis of UVB-reflected photographs. Since no strong relationship between any single predictive parameter and outcome was initially documented, we relied on artificial neural networks. Results: Using a time-response optimal threshold model, data were divided into 2 groups of responders and nonresponders. A discriminant network was trained in order to detect responders versus nonresponders. A regression network was subsequently used to compute repigmentation time in responders. The neural network discriminator achieved 66.46 ± 5.37% (95% CI) overall accuracy. The mean absolute error of the neural network regressor was 19.5843 ± 2.0930 with a root mean square error of 23.7156 ± 2.2225. Conclusion: Our study offers insight into the difficulty of clinical prediction in vitiligo and presents a way to develop an instrument with which to predict the clinical time response in patients treated by excimer laser.

Keywords:
Vitiligo, Laser treatment, clinical response, Neural network
1.
Kent G, Al’Abadie M: Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996;35:895–898.
2.
Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U: Interventions for vitiligo. Cochrane Database Syst Rev 2006;1:CD003263.
3.
Njoo MD, Westerhof W, Bos JD, Bossuyt PM: The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999;135:1514–1521.
4.
Lim HW, Hexsel CL: Vitiligo: to treat or not to treat. Arch Dermatol 2007;143:643–646.
5.
Baltas E, Csoma Z, Ignacz F, et al: Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002;138:1619–1620.
6.
Sassi F, Cazzaniga S, Tessari GP, Chatenoud L, et al: Randomised clinical trial comparing the effectiveness of 308 nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol 2008;159:1186–1191.
7.
Gonzalez R, Woods R: Digital Image Processing, ed 2. Englewood Cliffs, Prentice Hall, 2002.
8.
Lisboa PJG, Vellido A, Wong H: Outstanding Issues for Clinical Decision Support with Neural Networks. London, Springer, 2002, pp 63–71.
9.
Kanungo T, Mount DM, Netanyahu NS, Piatko CD, Silverman R, Wu AY: An efficient k-means clustering algorithm: analysis and implementation. PAMI 2002;7:881–892.
10.
MacKay DJC: Bayesian interpolation. Neural Comput 1992;4:415–447.
11.
MacKay DJC: A practical bayesian framework for backpropagation networks. Neural Comput 1992;4:448–472.
12.
Ganesh A, Abdesselam B: A generalized feed-forward neural network architecture for classification and regression. Neural Netw 2003;16:561–568.
13.
Jolliffe IT: Principal Component Analysis, ed 2. New York, Springer, 2002.
14.
Lawless JF, Fredette M: Frequentist prediction intervals and predictive distributions. Biometrika 2005;92:529–542.
15.
Kwasnicka H, Michalak K: Correlation-based feature selection strategy in neural classification. ISDA Proc 2006;1:741–746.
16.
Nicolaidou E, Antoniou C, Alexander JS, Stefanaki C, Katsambas AD: Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 2007;56:274–278.
17.
Dave S, Thappa DM, Dsouza M: Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol 2002;68:323–325.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.